AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Sitara-M 50/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitara-M 50/1000 Tablet ER

Diabetics with type 2 mellitus may be prescribed the extended-release combination medication, Sitara-M 50/1000, to manage elevated blood glucose. This dual-action therapy mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). Sitara-M 50/1000 ER can be used independently or in conjunction with other anti-diabetic treatments. Optimal results are achieved with a balanced diet and consistent physical activity. Dosage is individualized based on your health status, blood sugar readings, and existing medications. Consuming the medication with food minimizes gastrointestinal discomfort. For maximum effectiveness, maintain a consistent daily administration schedule; discontinuation should only occur under your physician's guidance. Adherence to the prescribed diet and exercise regime is crucial for successful diabetes control; lifestyle choices are key to effective management. Common adverse effects may include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and address this condition. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals must consult their physician. Interactions with other medications are possible; disclose all medications to ensure treatment safety. Alcohol should be avoided due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose throughout your treatment.

Primary Ingredients of Sitara-M 50/1000 Tablet ER

No text was provided to rewrite.

Uses of Sitara-M 50/1000 Tablet ER

Managing type 2 diabetes

Major Benefits of Sitara-M 50/1000 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. It's recommended to take Sitara-M 50/1000 Tablet ER with a meal.

Common Side effects of Sitara-M 50/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitara-M 50/1000 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Sitara-M 50/1000 Extended-Release tablet whole; do not break, crush, or chew it. Administer this medicine with a meal.

How Sitara-M 50/1000 Tablet ER works:

Sitara-M 50/1000 Extended-Release tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sitara-M 50/1000 Tablet ER and alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sitara-M 50/1000 tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sitara-M 50/1000 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitara-M 50/1000 Tablet ER; dosage modification may be necessary. Severe kidney disease contraindicates the use of Sitara-M 50/1000 Tablet ER. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The extended-release Sitara-M 50/1000 tablet is likely unsuitable for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.

What if you forget to take Sitara-M 50/1000 Tablet ER :

Should you forget a Sitara-M 50/1000 Tablet ER dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Sitara-M 50/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitara-M 50/1000 Tablet ER

Sitara-M 50/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Sitara-M 50/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Sitara-M 50/1000 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Sitara-M 50/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitara-M 50/1000 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 50/1000 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitara-M 50/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitara-M 50/1000 Tablet ER may cause common side effects including low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitara-M 50/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitara-M 50/1000 Tablet ER and alcohol is unsafe due to the increased risk of lactic acidosis.
Sitara-M 50/1000 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitara-M 50/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, along with potential cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 50/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication helps manage blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Sitara-M 50/1000 Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitara-M 50/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitara-M 50/1000 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitara-M 50/1000 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitara-M and seek immediate medical attention.
Prolonged Sitara-M 50/1000 Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. Preventive measures suggested by some researchers include annual supplemental vitamin B12 intake.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitara-M 50/1000 Tablet E...
99
MRP 115
13% off